dc.contributor.author
Xu, Shaohui
dc.contributor.author
Zhong, Yinan
dc.contributor.author
Nie, Chuanxiong
dc.contributor.author
Pan, Yuanwei
dc.contributor.author
Adeli, Mohsen
dc.contributor.author
Haag, Rainer
dc.date.accessioned
2021-11-15T13:22:53Z
dc.date.available
2021-11-15T13:22:53Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/32501
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-32226
dc.description.abstract
2D MoS2 has shown a great potential in biomedical applications, due to its superior loading capacity, photothermal property, and biodegradation. In this work, polyglycerol functionalized MoS2 nanosheets with photothermal and pH dual-stimuli responsive properties are used for the co-delivery of doxorubicin and chloroquine and treatment of multidrug-resistant HeLa (HeLa-R) cells. The polyglycerol functionalized MoS2 nanosheets with 80 nm average size show a high biocompatibility and loading efficiency (≈90%) for both drugs. The release of drugs from the nanosheets at pH 5.5 is significantly promoted by laser irradiation leading to efficient destruction of incubated HeLa-R cells. In vitro evaluation shows that the designed nanoplatform has a high ability to kill HeLa-R cells. Confocal experiments demonstrate that the synthesized drug delivery system enhances the cellular uptake of DOX via folic acid targeting ligand. Taking advantage of the combined properties including biocompatibility and targeting ability as well as high loading capacity and photothermal release, this multifunctional nanosystem is a promising candidate for anticancer therapy.
en
dc.format.extent
9 Seiten
dc.rights.uri
https://creativecommons.org/licenses/by-nc/4.0/
dc.subject
anticancer drug delivery
en
dc.subject
hyperbranched polyglycerol
en
dc.subject
multidrug-resistant cancer
en
dc.subject.ddc
500 Naturwissenschaften und Mathematik::570 Biowissenschaften; Biologie::570 Biowissenschaften; Biologie
dc.title
Co-Delivery of Doxorubicin and Chloroquine by Polyglycerol Functionalized MoS2 Nanosheets for Efficient Multidrug-Resistant Cancer Therapy
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
2100233
dcterms.bibliographicCitation.doi
10.1002/mabi.202100233
dcterms.bibliographicCitation.journaltitle
Macromolecular Bioscience
dcterms.bibliographicCitation.number
11
dcterms.bibliographicCitation.volume
21
dcterms.bibliographicCitation.url
https://doi.org/10.1002/mabi.202100233
refubium.affiliation
Biologie, Chemie, Pharmazie
refubium.affiliation.other
Institut für Chemie und Biochemie

refubium.funding
DEAL Wiley
refubium.note.author
Die Publikation wurde aus Open Access Publikationsgeldern der Freien Universität Berlin gefördert.
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
1616-5195